Literature DB >> 10382903

Erythromycin resistance amongst group A beta-haemolytic streptococci isolated in a paediatric hospital in Athens, Greece.

E Tzelepi, G Kouppari, A Mavroidi, A Zaphiropoulou, L S Tzouvelekis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10382903     DOI： 10.1093/jac/43.5.745

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  5 in total

1.  Resistance to erythromycin and telithromycin in Streptococcus pyogenes isolates obtained between 1999 and 2002 from Greek children with tonsillopharyngitis: phenotypic and genotypic analysis.

Authors:  Ioanna N Grivea; Adnan Al-Lahham; George D Katopodis; George A Syrogiannopoulos; Ralf René Reinert
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

2.  Comparative in vitro activities of linezolid, quinupristin-dalfopristin, moxifloxacin, and trovafloxacin against erythromycin-susceptible and -resistant streptococci.

Authors:  C Betriu; M Redondo; M L Palau; A Sánchez; M Gómez; E Culebras; A Boloix; J J Picazo
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

3.  Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients.

Authors:  E Bingen; F Fitoussi; C Doit; R Cohen; A Tanna; R George; C Loukil; N Brahimi; I Le Thomas; D Deforche
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

4.  Resistance determinants and clonal diversity in group A streptococci collected during a period of increasing macrolide resistance.

Authors:  Stefania Cresti; Maria Lattanzi; Alessandra Zanchi; Francesca Montagnani; Simona Pollini; Carla Cellesi; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

Review 5.  [Patient consent to "antimicrobial treatment of tonsillitis"].

Authors:  C Cenjor; J A García-Rodríguez; A Ramos; J Cervera; M Tomás; F Asensi; J L Cañada; M Gobernado; T Isasiá; C López-Madroñero; M Martínez; F Pérez-Escanilla; J Picazo; J Prieto; T Sampelayo
Journal:  Acta Otorrinolaringol Esp       Date:  2003-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.